JP2015523963A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523963A5 JP2015523963A5 JP2015511433A JP2015511433A JP2015523963A5 JP 2015523963 A5 JP2015523963 A5 JP 2015523963A5 JP 2015511433 A JP2015511433 A JP 2015511433A JP 2015511433 A JP2015511433 A JP 2015511433A JP 2015523963 A5 JP2015523963 A5 JP 2015523963A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cancer
- composition according
- effective amount
- therapeutically effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/466,827 US8841350B2 (en) | 2011-05-11 | 2012-05-08 | Method for inducing UDP-glucuronosyltransferase activity using pterostilbene |
| US13/466,827 | 2012-05-08 | ||
| PCT/US2012/064993 WO2013169291A2 (en) | 2012-05-08 | 2012-11-14 | Method for inducing udp-glucuronosyltransferase activity using pterostilbene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015523963A JP2015523963A (ja) | 2015-08-20 |
| JP2015523963A5 true JP2015523963A5 (https=) | 2015-10-29 |
Family
ID=47142275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511433A Pending JP2015523963A (ja) | 2012-05-08 | 2012-11-14 | プテロスチルベンを使用してｕｄｐ−グルクロノシルトランスフェラーゼ活性を誘導する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8841350B2 (https=) |
| EP (1) | EP2846785A4 (https=) |
| JP (1) | JP2015523963A (https=) |
| KR (1) | KR20150027081A (https=) |
| CN (1) | CN104768543A (https=) |
| AU (1) | AU2012379655B2 (https=) |
| BR (1) | BR112014027646A2 (https=) |
| CA (1) | CA2872623A1 (https=) |
| IN (1) | IN2014DN09990A (https=) |
| MX (1) | MX2014013503A (https=) |
| WO (1) | WO2013169291A2 (https=) |
| ZA (1) | ZA201408893B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107106877A (zh) * | 2014-09-04 | 2017-08-29 | 加利福尼亚大学董事会 | 用于治疗uv诱发的皮肤屏障功能受损的局部用蝶芪组合物 |
| US20160067193A1 (en) * | 2014-09-04 | 2016-03-10 | The Regents Of The University Of California | Topical pterostilbene compositions for use in treating uv-induced skin damage and hyperplasia |
| JP2018517774A (ja) | 2015-06-10 | 2018-07-05 | エリジウム・ヘルス・インコーポレイテッド | ニコチンアミドリボシドおよびプテロスチルベン組成物ならびに皮膚障害の処置のための方法 |
| US12134956B2 (en) | 2022-10-11 | 2024-11-05 | Halliburton Energy Services, Inc. | Liner hanger system |
| US12398624B2 (en) | 2023-07-11 | 2025-08-26 | Halliburton Energy Services, Inc. | Self-energizing seal for expandable liner hanger |
| US12509957B1 (en) | 2024-09-16 | 2025-12-30 | Halliburton Energy Services, Inc. | Partially bonded seals for well systems |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6623724B2 (en) * | 1996-09-18 | 2003-09-23 | Applied Genetics Incorporated Dermatics | Dermatological compositions and methods |
| US6414037B1 (en) * | 1998-01-09 | 2002-07-02 | Pharmascience | Pharmaceutical formulations of resveratrol and methods of use thereof |
| DE10161253A1 (de) | 2001-12-13 | 2003-06-26 | Dragoco Gerberding Co Ag | Verwendung von Dihydropinosylvin und dessen Derivaten als Inhibitoren |
| FR2869229B1 (fr) | 2004-04-26 | 2006-08-25 | Sederma Soc Par Actions Simpli | Utilisation d'un inducteur des ugt par voie topique |
| ES2246165B1 (es) | 2004-07-20 | 2006-12-01 | Universitat De Valencia | Uso combinado del pteroestilbeno y la quercetina para la fabricacion de medicamentos utiles en el tratamiento del cancer. |
| WO2008070872A1 (en) | 2006-12-07 | 2008-06-12 | Rutgers, The State University Of New Jersey | Prevention and treatment of colon cancer |
| US8509879B2 (en) | 2007-11-06 | 2013-08-13 | The Regents Of The University Of California | Apparatus and method for widefield functional imaging (WiFI) using integrated structured illumination and laser speckle imaging |
| WO2009089334A1 (en) * | 2008-01-08 | 2009-07-16 | David Rubin | Method and compositions for preserving wine |
| US20090324740A1 (en) | 2008-06-13 | 2009-12-31 | Albritton Iv Ford D | Novel nasal spray |
| US20100240767A1 (en) | 2009-03-23 | 2010-09-23 | Muhammed Majeed | Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof |
| US9737495B2 (en) | 2009-06-22 | 2017-08-22 | Indus Biotech Private Limited | Process for obtaining purified pterostilbene and methods of use thereof |
| WO2011042482A1 (en) * | 2009-10-06 | 2011-04-14 | Green Molecular | Polyphenols for use in the treatment of cancer |
| EP2322159A1 (en) | 2009-10-30 | 2011-05-18 | Green Molecular, S.L. | Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic |
| US8318807B2 (en) * | 2010-02-03 | 2012-11-27 | Laurus Labs Private Limited | Pterostilbene cocrystals |
| US8883218B2 (en) * | 2010-03-26 | 2014-11-11 | The Board Of Trustees Of The University Of Arkansas | Anti-cancer nanoparticle compositions and methods of use |
| MX344772B (es) | 2011-01-28 | 2017-01-06 | Univ Kentucky Res Found | Analogos de estilbeno y metodos para tratar cancer. |
| JP6155191B2 (ja) * | 2011-10-02 | 2017-06-28 | キユーピー株式会社 | ＲＮＡ干渉によるｍＲＮＡ発現の抑制を促進する促進剤およびその用途 |
-
2012
- 2012-05-08 US US13/466,827 patent/US8841350B2/en active Active - Reinstated
- 2012-11-14 WO PCT/US2012/064993 patent/WO2013169291A2/en not_active Ceased
- 2012-11-14 EP EP12876092.3A patent/EP2846785A4/en not_active Withdrawn
- 2012-11-14 KR KR20147034337A patent/KR20150027081A/ko not_active Withdrawn
- 2012-11-14 AU AU2012379655A patent/AU2012379655B2/en not_active Expired - Fee Related
- 2012-11-14 BR BR112014027646A patent/BR112014027646A2/pt not_active IP Right Cessation
- 2012-11-14 CN CN201280074486.2A patent/CN104768543A/zh active Pending
- 2012-11-14 IN IN9990DEN2014 patent/IN2014DN09990A/en unknown
- 2012-11-14 MX MX2014013503A patent/MX2014013503A/es unknown
- 2012-11-14 CA CA2872623A patent/CA2872623A1/en not_active Abandoned
- 2012-11-14 JP JP2015511433A patent/JP2015523963A/ja active Pending
-
2014
- 2014-09-22 US US14/493,058 patent/US10039725B2/en active Active - Reinstated
- 2014-12-04 ZA ZA2014/08893A patent/ZA201408893B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015523963A5 (https=) | ||
| GEP201706678B (en) | Method of treating cancer and bone cancer | |
| PH12016502132A1 (en) | Aryl-or heteroaryl-substituted benzene compounds | |
| BR112016011078A8 (pt) | derivados de 1-(5-terc-butil-2-arilpirazol-3-il)-3-[2-flúor-4-[(3-oxo-4h-pirido[2,3-b]pirazin-8- il)óxi]fenil]ureia, seus usos, sua composição farmacêutica, método para preparar a mesma e método in vitro para inibir a função raf em uma célula | |
| BR112015008447A2 (pt) | métodos para tratar câncer | |
| RU2013131004A (ru) | Комбинация (а) ингибитора фосфоинозит-3-киназы и (б) модулятора пути ras/raf/mek | |
| NZ700881A (en) | Compositions and methods comprising celecoxib or related compounds and dextromethorphan | |
| BR112015027400A2 (pt) | Anticorpos capazes de se ligar especificamente ao her2 | |
| RU2015121367A (ru) | Фармацевтическая комбинация, содержащая ингибитор b-raf и ингибитор деацетилазы гистонов, и ее применение при лечении пролиферативных заболеваний | |
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| UA117451C2 (uk) | Терапевтично активні сполуки і способи їх застосування | |
| BR102012006063A8 (pt) | Inibidor de met para uso no tratamento de um paciente sofrendo de um tumor, e, sequência de nucleotídeo | |
| WO2016051398A8 (en) | Patient-specific immunotherapy for treating heterogeneous tumors | |
| NZ608207A (en) | Breast cancer therapeutics | |
| IN2014DN09228A (https=) | ||
| JP2014509653A5 (https=) | ||
| EP2682459A4 (en) | ONCOLYTIC ADENOVIRES FOR A TEMPORARY THERAPY AND USE THEREOF | |
| RU2015152785A (ru) | Лечение злокачественной опухоли налтрексоном | |
| JP2013544892A5 (https=) | ||
| JP2015507020A5 (https=) | ||
| JP2015527374A5 (https=) | ||
| WO2012142615A3 (en) | Auranofin and auranofin analogs useful to treat proliferative disease and disorders | |
| MX2011008994A (es) | Metodos de usar sns - 595 para el tratamiento de sujetos con cancer con actividad reducida de brca2. | |
| JP2015506352A5 (https=) | ||
| JP2017525738A5 (https=) |